Research / NVT / Fundamental state Inspectable configuration
State dimensions Filing 0001628280-26-029370 General Corporate
Debt relative to revenue 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
125.34% · OPTIONAL · VALID
Capex intensity 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.91% · OPTIONAL · VALID
Operating cash generation 10th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
6.86% · OPTIONAL · VALID
Share-count growth 15th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.shares_outstanding
-1.77% · CORE · VALID
Revenue growth 100th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
53.47% · CORE · VALID
Inventory pressure 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
41.22% · OPTIONAL · VALID
Gross margin 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
35.88% · CORE · VALID
Operating margin 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
15.76% · CORE · VALID
R&D intensity 0th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.83% · OPTIONAL · VALID
SBC intensity 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
1.32% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Sep 30, 2021 10/10 normalized Level 3 Dec 31, 2021 10/10 normalized Level 3 Mar 31, 2022 10/10 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 10/10 normalized Level 3 Mar 31, 2023 10/10 normalized Level 3 Jun 30, 2023 10/10 normalized Level 3 Sep 30, 2023 10/10 normalized Level 3 Dec 31, 2023 10/10 normalized Level 3 Mar 31, 2024 10/10 normalized Level 3 Jun 30, 2024 10/10 normalized Level 3 Sep 30, 2024 10/10 normalized Level 3 Dec 31, 2024 10/10 normalized Level 3 Mar 31, 2025 10/10 normalized Level 3 Jun 30, 2025 10/10 normalized Level 3 Sep 30, 2025 10/10 normalized Level 3 Dec 31, 2025 10/10 normalized Level 3 Mar 31, 2026 10/10 normalized Level 3 Jun 30, 2026 10/10 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 40.07%
Current 125.34%
Delta 85.27% Capex Intensity Increased
Previous 2.40%
Current 2.91%
Delta 0.51% Cash Generation Decreased
Previous 11.95%
Current 6.86%
Delta -5.09% Dilution Increased
Previous -2.00%
Current -1.77%
Delta 0.22% Growth Increased
Previous 29.51%
Current 53.47%
Delta 23.96% Inventory Pressure Increased
Previous 12.12%
Current 41.22%
Delta 29.10% Margin Decreased
Previous 37.74%
Current 35.88%
Delta -1.86% Profitability Decreased
Previous 15.84%
Current 15.76%
Delta -0.09% R And D Intensity Decreased
Previous 2.02%
Current 1.83%
Delta -0.19% Sbc Intensity Increased
Previous 0.96%
Current 1.32%
Delta 0.36% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.